{"id":"W2969622176","doi":"10.1200/jco.2012.30.15_suppl.e13123","title":"Effect of VAL-083, a novel N7 alkylating agent, on growth of temolozomide-resistant primary adult glioblastoma multiforme (GBM) cells providing a new potential treatment option for GBM.","year":2012,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"ca_institutions":"BC Cancer Agency; Celator Pharmaceuticals (Canada); University of British Columbia","funders":"","keywords":"Temozolomide; Cancer research; Medicine; Neurosphere; Growth inhibition; Cell culture; Brain tumor; Cancer stem cell; Glioblastoma; Dacarbazine; Cancer; In vitro; Oncology; Internal medicine; Pathology; Biology; Melanoma; Adult stem cell","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00008295921,0.0002275518,0.0002289016,0.00009853461,0.0001095584,0.0001268853,0.0001981379,0.0002217088,0.001484448],"category_scores_gemma":[0.00007468559,0.00007813077,0.0002315687,0.0001169255,0.0001221688,0.0001019316,0.00009197091,0.0005277525,0.0002726816],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001906977,"about_ca_system_score_gemma":0.0002377649,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.002601607,"about_ca_topic_score_gemma":0.004543832,"domain_scores_codex":[0.9999487,0.000009900926,0.000006490623,0.000009541935,0.00001058682,0.00001472745],"domain_scores_gemma":[0.9999385,0.00001760875,0.000009544931,0.000006271598,0.000007700525,0.00002039686],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.002124705,0.0006811804,0.001081299,0.0001159235,0.00002548289,0.000118119,0.00005911612,0.0002625085,0.9861097,0.00008550343,0.0005301938,0.008806419],"study_design_scores_gemma":[0.0002421154,0.01461377,0.02586717,0.00001599624,0.00005572856,0.0004886078,0.00006827062,0.001748578,0.953005,0.00002996884,0.003852636,0.00001209003],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9976514,0.000883452,0.0001472218,0.00004932574,0.00002767813,0.00001905219,0.0003918491,0.00002457758,0.0008054181],"genre_scores_gemma":[0.9957556,0.0009456324,0.0007437972,0.00007515366,0.000008869385,0.000031377,0.001014265,0.000009105565,0.001416175],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.002601607,"threshold_uncertainty_score":0.005172968,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.06421470740754004,"score_gpt":0.4118518637645817,"score_spread":0.3476371563570416,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}